pH and Redox Dual-Responsive Nanoparticle with Enhanced Dendritic Cell Maturation for Cancer Therapy DOI
Do Hyun Yun,

Erinn Fagan,

Dongik Shin

et al.

ACS Applied Materials & Interfaces, Journal Year: 2024, Volume and Issue: 16(47), P. 64592 - 64608

Published: Nov. 13, 2024

Type I interferons (IFNs) are essential for activating dendritic cells (DCs) and presenting tumor-associated antigens to T cells. IFNs primarily produced from DCs among immune A combination of chemotherapy metalloimmunotherapy induces IFN production by the cyclic GMP-AMP synthase-stimulator interferon genes (cGAS-STING) pathway. However, chemotherapeutic agents deplete DC populations, suppressing immunostimulatory activities, despite their potent anticancer activities. Furthermore, an optimal ratio between metal at highest level has not been reported, evidence ensuring survival is lacking. In this study, we hypothesized that there yield maturation activity with minimal depletion. To demonstrate it, have designed a pH redox dual-responsive nanoparticle, MnO2@BSA@DOX (MD), prevent depleting activate cGAS-STING pathway both in cancer DCs, inducing considerable levels maturation. MD consists core-layer structure, manganese dioxide (MnO2) core, cross-linked layer bovine serum albumin (BSA) doxorubicin (DOX), specific DOX manganese. exhibits structure-based selectivity targeting extracellular tumor microenvironment intracellular reactions Among various formulations, 1:1 shows no significant Moreover, it distinct cytotoxicity through apoptosis activation, leading increased calreticulin expression enhanced phagocytosis. Consequently, results superior suppression prolonged high accumulation observed systemic toxicities, highlighting its potential as therapeutic agent treatments.

Language: Английский

Tumor microenvironment as a complex milieu driving cancer progression: a mini review DOI Creative Commons
Zhengrui Li, Jing Li,

Xiaolei Bai

et al.

Clinical & Translational Oncology, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 28, 2024

Language: Английский

Citations

23

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer DOI Creative Commons
Shan Liu,

Xingda Zhang,

Wenzheng Wang

et al.

Molecular Cancer, Journal Year: 2024, Volume and Issue: 23(1)

Published: Nov. 21, 2024

Metabolic alterations, a hallmark of cancer, enable tumor cells to adapt their environment by modulating glucose, lipid, and amino acid metabolism, which fuels rapid growth contributes treatment resistance. In primary breast metabolic shifts such as the Warburg effect enhanced lipid synthesis are closely linked chemotherapy failure. Similarly, metastatic lesions often display distinct profiles that not only sustain but also confer resistance targeted therapies immunotherapies. The review emphasizes two major aspects: mechanisms driving in both how unique environments sites further complicate treatment. By targeting vulnerabilities at stages, new strategies could improve efficacy existing provide better outcomes for cancer patients.

Language: Английский

Citations

18

Intra-tumoral bacteria in breast cancer and intervention strategies DOI
Ting Hou, Xiaoling Huang,

Jiahui Lai

et al.

Advanced Drug Delivery Reviews, Journal Year: 2025, Volume and Issue: unknown, P. 115516 - 115516

Published: Jan. 1, 2025

Language: Английский

Citations

2

Progress of tumor-resident intracellular bacteria for cancer therapy DOI

Peng Bao,

Xian‐Zheng Zhang

Advanced Drug Delivery Reviews, Journal Year: 2024, Volume and Issue: 214, P. 115458 - 115458

Published: Oct. 9, 2024

Language: Английский

Citations

3

Tumor‐Resident Intracellular Bacteria Scavenger Activated In Situ Vaccines for Potent Cancer Photoimmunotherapy DOI Open Access

Bai Lv,

Yifan Zhao, Gang Li

et al.

Advanced Healthcare Materials, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 13, 2025

Abstract In situ tumor vaccines, which utilize antigens generated during treatment to stimulate a cancer patient's immune system, has become potential field in immunotherapy. However, due the immunosuppressive microenvironment (ITME), generation of is always mild and not sufficient. Tumor‐resident intracellular bacteria have been identified as complete component contribute creating ITME. Herein, tumor‐resident scavenger designed induce enhanced antitumor photoimmunotherapy‐driven vaccines for treating hypoxic tumors. This developed by integrating photosensitizer CyI antibiotics Doxycycline (Doxy) into thermal‐sensitive tumor‐derived exosomes fused liposomes (ECDL). vitro vivo results showed that ECDL could homologous target cells restrict respiration mitochondrial reduce hypoxia, thus providing continuous oxygen eliminate both bacteria, ablating primary inhibiting metastasis recurrence. Moreover, eliminating neutralizes ITME triggers production bacterial‐related neoantigens, further strength study provided versatile effective are promising local, abscopal, metastatic treatment.

Language: Английский

Citations

0

Lactobacillus gasseri prevents ibrutinib-associated atrial fibrillation through butyrate DOI Creative Commons
Ling Shi, Yu Duan, Ning Fang

et al.

EP Europace, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 17, 2025

Ibrutinib, a widely used anti-cancer drug, is known to significantly increase the susceptibility atrial fibrillation (AF). While it recognized that drugs can reshape gut microbiota, influencing both therapeutic effectiveness and adverse events, role of microbiota in ibrutinib-induced AF remains largely unexplored. Utilizing 16S rRNA gene sequencing, fecal transplantation, metabonomics, electrophysiological examination, molecular biology methodologies, we sought validate hypothesis dysbiosis promotes ibrutinib-associated elucidate underlying mechanisms. We found ibrutinib administration predisposes rats AF. Interestingly, microbial transplantation conferred increased rats. Notably, induced decrease abundance Lactobacillus gasseri (L. gasseri), oral supplementation L. or its metabolite, butyrate, effectively prevented from Mechanistically, butyrate inhibits generation reactive oxygen species (ROS), thereby ameliorating structural remodeling. Furthermore, demonstrated inhibited growth by disrupting intestinal barrier integrity. Collectively, our findings provide compelling experimental evidence supporting potential efficacy targeting microbes preventing AF, opening new avenues for interventions.

Language: Английский

Citations

0

Interactions between the tumor microbiota and breast cancer DOI Creative Commons
Hua Guo

Frontiers in Cellular and Infection Microbiology, Journal Year: 2025, Volume and Issue: 14

Published: Jan. 24, 2025

Breast cancer is the most common malignancy in women worldwide. Changes microbiota and their metabolites affect occurrence development of breast cancer; however, specific mechanisms are not clear. Gut microbes influence by regulating tumor immune response, estrogen metabolism, chemotherapy, immunotherapy effects. It was previously thought that there were no microorganisms tissue, but it now can outcome disease. This review builds on existing research to comprehensively analyze role gut intratumoral metastasis cancer. We also explore potential function as biomarkers for prognosis therapeutic highlighting need further clarify causal relationship between hope provide new ideas directions methods treatment.

Language: Английский

Citations

0

Self-assembled supramolecular nanofibers integrate pH-responsive drug delivery and antimicrobial for combined cancer therapy DOI
Ting Zhang, Deqiang Chen, Ningzhi Zhang

et al.

Chinese Chemical Letters, Journal Year: 2025, Volume and Issue: unknown, P. 111117 - 111117

Published: March 1, 2025

Language: Английский

Citations

0

Interplay between the gut microbiota, its metabolites and carcinogens DOI
Huan Sun, Qixiao Zhai,

Juan Liu

et al.

Clinical & Translational Oncology, Journal Year: 2025, Volume and Issue: unknown

Published: May 13, 2025

Language: Английский

Citations

0

Golden insights for exploring cancer: delivery, from genes to the human body using bimetallic Au/Ag nanostructures DOI Creative Commons
Misbah Ullah Khan, Humaira Aslam, Muhammad Jehanzeb Sohail

et al.

Discover Oncology, Journal Year: 2025, Volume and Issue: 16(1)

Published: May 25, 2025

Sweeping contact with cancer continues to rise globally, which has led advanced research on new treatment approaches; nanotechnology become crucial targeted therapy. Within the intimate of nanomaterials, Au/Ag nanostructures have emerged as highly attractive because their distinctive desirable characteristics and prospective roles in diagnosis well The developed revealed remarkable biocompatibility, optically recursive alteration, magnificently improved therapeutic effects gold silver conjunction each other. This review addresses molecular systemic aspects research, including impact genetic pathways use administration human organism. We explain some related mechanisms action, such photothermal therapy (PTT), photodynamic (PDT), drug delivery systems where they display potential benefits towards offering a more approach fewer side effects. latest development shown that prospect real-time imaging biomarker identification, owing this are being viewed tool for individualized treatment. However, there still limitations: challenges scaling up, biological safety, bringing it clinic. It is therefore incumbent upon these managements overcome hurdles optimize impact. As result, current findings briefly reviewed, directions discussed support revolutionary role

Language: Английский

Citations

0